188 related articles for article (PubMed ID: 31014286)
1. Advanced assessment of migration and invasion of cancer cells in response to mifepristone therapy using double fluorescence cytochemical labeling.
Ritch SJ; Brandhagen BN; Goyeneche AA; Telleria CM
BMC Cancer; 2019 Apr; 19(1):376. PubMed ID: 31014286
[TBL] [Abstract][Full Text] [Related]
2. Cytostasis and morphological changes induced by mifepristone in human metastatic cancer cells involve cytoskeletal filamentous actin reorganization and impairment of cell adhesion dynamics.
Brandhagen BN; Tieszen CR; Ulmer TM; Tracy MS; Goyeneche AA; Telleria CM
BMC Cancer; 2013 Jan; 13():35. PubMed ID: 23351358
[TBL] [Abstract][Full Text] [Related]
3. The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristone.
Ritch SJ; Noman ASM; Goyeneche AA; Telleria CM
Cancer Cell Int; 2022 Dec; 22(1):397. PubMed ID: 36494669
[TBL] [Abstract][Full Text] [Related]
4. Antiprogestin mifepristone inhibits the growth of cancer cells of reproductive and non-reproductive origin regardless of progesterone receptor expression.
Tieszen CR; Goyeneche AA; Brandhagen BN; Ortbahn CT; Telleria CM
BMC Cancer; 2011 May; 11():207. PubMed ID: 21619605
[TBL] [Abstract][Full Text] [Related]
5. Response of human ovarian carcinoma cell lines to antiprogestin mifepristone.
Rose FV; Barnea ER
Oncogene; 1996 Mar; 12(5):999-1003. PubMed ID: 8649817
[TBL] [Abstract][Full Text] [Related]
6. Inositol hexaphosphate (IP6) inhibits key events of cancer metastasis: I. In vitro studies of adhesion, migration and invasion of MDA-MB 231 human breast cancer cells.
Tantivejkul K; Vucenik I; Shamsuddin AM
Anticancer Res; 2003; 23(5A):3671-9. PubMed ID: 14666663
[TBL] [Abstract][Full Text] [Related]
7. The β 2-Adrenergic Agonist Salbutamol Inhibits Migration, Invasion and Metastasis of the Human Breast Cancer MDA-MB- 231 Cell Line.
Rivero EM; Piñero CP; Gargiulo L; Entschladen F; Zänker K; Bruzzone A; Lüthy IA
Curr Cancer Drug Targets; 2017; 17(8):756-766. PubMed ID: 28359245
[TBL] [Abstract][Full Text] [Related]
8. HAMPT, A Novel Quadruple Drug Combination Designed for Cancer Metastatic Chemoprevention: From Hypothesis to Proof-of-concept.
Xu H; Wan L; Xu J; Liu J; Zheng N; Jia L
Curr Cancer Drug Targets; 2019; 19(4):296-303. PubMed ID: 30968769
[TBL] [Abstract][Full Text] [Related]
9. Mifepristone induces growth arrest, caspase activation, and apoptosis of estrogen receptor-expressing, antiestrogen-resistant breast cancer cells.
Gaddy VT; Barrett JT; Delk JN; Kallab AM; Porter AG; Schoenlein PV
Clin Cancer Res; 2004 Aug; 10(15):5215-25. PubMed ID: 15297425
[TBL] [Abstract][Full Text] [Related]
10. New HIV-drug inhibits in vitro bladder cancer migration and invasion.
Retz M; Sidhu SS; Lehmann J; Tamamura H; Fujii N; Basbaum C
Eur Urol; 2005 Dec; 48(6):1025-30. PubMed ID: 16140456
[TBL] [Abstract][Full Text] [Related]
11. Ubenimex inhibits cell proliferation, migration and invasion by inhibiting the expression of APN and inducing autophagic cell death in prostate cancer cells.
Wang X; Niu Z; Jia Y; Cui M; Han L; Zhang Y; Liu Z; Bi D; Liu S
Oncol Rep; 2016 Apr; 35(4):2121-30. PubMed ID: 26846372
[TBL] [Abstract][Full Text] [Related]
12. Abortifacient metapristone (RU486 derivative) interrupts CXCL12/CXCR4 axis for ovarian metastatic chemoprevention.
Zheng N; Chen J; Li T; Liu W; Liu J; Chen H; Wang J; Jia L
Mol Carcinog; 2017 Aug; 56(8):1896-1908. PubMed ID: 28277622
[TBL] [Abstract][Full Text] [Related]
13. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
Afify A; Purnell P; Nguyen L
Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
[TBL] [Abstract][Full Text] [Related]
15. Effects of mifepristone on invasive and metastatic potential of human gastric adenocarcinoma cell line MKN-45 in vitro and in vivo.
Li DQ; Wang ZB; Bai J; Zhao J; Wang Y; Hu K; Du YH
World J Gastroenterol; 2004 Jun; 10(12):1726-9. PubMed ID: 15188494
[TBL] [Abstract][Full Text] [Related]
16. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
[TBL] [Abstract][Full Text] [Related]
17. [Effect of Aloe emodin on invasion and metastasis of high metastatic breast cancer MDA-MB-231 cells].
He ZH; Huang YQ; Weng SF; Tan YR; He TP; Qin YM; Liang NC
Zhong Yao Cai; 2013 Sep; 36(9):1481-5. PubMed ID: 24620697
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of mixed properties of RU486 in progesterone receptor (PR)-transfected MDA-MB-231 cells: a model for studying the functions of progesterone analogues.
Lin VC; Aw SE; Ng EH; Ng EH; Tan MG
Br J Cancer; 2001 Dec; 85(12):1978-86. PubMed ID: 11747343
[TBL] [Abstract][Full Text] [Related]
19. Suppression of human breast cancer cell metastasis by coptisine in vitro.
Li J; Qiu DM; Chen SH; Cao SP; Xia XL
Asian Pac J Cancer Prev; 2014; 15(14):5747-51. PubMed ID: 25081696
[TBL] [Abstract][Full Text] [Related]
20. Metapristone (RU486 derivative) inhibits cell proliferation and migration as melanoma metastatic chemopreventive agent.
Zheng N; Chen J; Liu W; Wang J; Liu J; Jia L
Biomed Pharmacother; 2017 Jun; 90():339-349. PubMed ID: 28376402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
